Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Status and perspectives on chronic myeloproliferative neoplasm treatment].
Ocias LF, Holmström MO, Riley CH, Andersen CL, Rønnov-Jessen D, Starklint J, Frederiksen M, Steffensen MS, Bjerrum OW, Farmer S, Mourits-Andersen T, Hasselbalch HC, Larsen TS. Ocias LF, et al. Among authors: holmstrom mo. Ugeskr Laeger. 2015 May 4;177(19):V12140652. Ugeskr Laeger. 2015. PMID: 25967090 Free article. Review. Danish.
[New disease markers within the chronic myeloproliferative neoplasms].
Holmström MO, Ocias LF, Kallenbach K, Kjær L, Kristensen TK, Pallisgaard N, Petersen BL, Skov V, de Stricker K, Larsen TS, Hasselbalch HC. Holmström MO, et al. Ugeskr Laeger. 2015 May 4;177(19):V12140653. Ugeskr Laeger. 2015. PMID: 25967091 Free article. Review. Danish.
Sorted peripheral blood cells identify CALR mutations in B- and T-lymphocytes.
Kjaer L, Holmström MO, Cordua S, Andersen MH, Svane IM, Thomassen M, Kruse TA, Pallisgaard N, Skov V, Hasselbalch HC. Kjaer L, et al. Among authors: holmstrom mo. Leuk Lymphoma. 2018 Apr;59(4):973-977. doi: 10.1080/10428194.2017.1359743. Epub 2017 Aug 9. Leuk Lymphoma. 2018. PMID: 28792253 No abstract available.
Cancer immune therapy for lymphoid malignancies: recent advances.
Klausen U, Jørgensen NGD, Grauslund JH, Holmström MO, Andersen MH. Klausen U, et al. Among authors: holmstrom mo. Semin Immunopathol. 2019 Jan;41(1):111-124. doi: 10.1007/s00281-018-0696-7. Epub 2018 Jul 13. Semin Immunopathol. 2019. PMID: 30006739 Review.
JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation.
Czech J, Cordua S, Weinbergerova B, Baumeister J, Crepcia A, Han L, Maié T, Costa IG, Denecke B, Maurer A, Schubert C, Feldberg K, Gezer D, Brümmendorf TH, Müller-Newen G, Mayer J, Racil Z, Kubesova B, Knudsen T, Sørensen AL, Holmström M, Kjær L, Skov V, Larsen TS, Hasselbalch HC, Chatain N, Koschmieder S. Czech J, et al. Leukemia. 2019 Apr;33(4):995-1010. doi: 10.1038/s41375-018-0295-6. Epub 2018 Nov 23. Leukemia. 2019. PMID: 30470838
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms.
Handlos Grauslund J, Holmström MO, Jørgensen NG, Klausen U, Weis-Banke SE, El Fassi D, Schöllkopf C, Clausen MB, Gjerdrum LMR, Breinholt MF, Kjeldsen JW, Hansen M, Koschmieder S, Chatain N, Novotny GW, Petersen J, Kjær L, Skov V, Met Ö, Svane IM, Hasselbalch HC, Andersen MH. Handlos Grauslund J, et al. Among authors: holmstrom mo. Front Oncol. 2021 Feb 26;11:637420. doi: 10.3389/fonc.2021.637420. eCollection 2021. Front Oncol. 2021. PMID: 33718228 Free PMC article.
Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression.
Carnaz Simões AM, Holmström MO, Aehnlich P, Rahbech A, Radziwon-Balicka A, Zamora C, Wirenfeldt Klausen T, Skov V, Kjær L, Ellervik C, Fassi DE, Vidal S, Hasselbalch HC, Andersen MH, Thor Straten P. Carnaz Simões AM, et al. Among authors: holmstrom mo. Front Immunol. 2022 May 6;13:866610. doi: 10.3389/fimmu.2022.866610. eCollection 2022. Front Immunol. 2022. PMID: 35603202 Free PMC article.
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.
Gigoux M, Holmström MO, Zappasodi R, Park JJ, Pourpe S, Bozkus CC, Mangarin LMB, Redmond D, Verma S, Schad S, George MM, Venkatesh D, Ghosh A, Hoyos D, Molvi Z, Kamaz B, Marneth AE, Duke W, Leventhal MJ, Jan M, Ho VT, Hobbs GS, Knudsen TA, Skov V, Kjær L, Larsen TS, Hansen DL, Lindsley RC, Hasselbalch H, Grauslund JH, Lisle TL, Met Ö, Wilkinson P, Greenbaum B, Sepulveda MA, Chan T, Rampal R, Andersen MH, Abdel-Wahab O, Bhardwaj N, Wolchok JD, Mullally A, Merghoub T. Gigoux M, et al. Among authors: holmstrom mo. Sci Transl Med. 2022 Jun 15;14(649):eaba4380. doi: 10.1126/scitranslmed.aba4380. Epub 2022 Jun 15. Sci Transl Med. 2022. PMID: 35704596 Free PMC article.
Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression.
Simões AMC, Holmström MO, Aehnlich P, Rahbech A, Peeters MJW, Radziwon-Balicka A, Zamora C, Klausen TW, Skov V, Kjær L, Ellervik C, Fassi DE, Vidal S, Hasselbalch HC, Andersen MH, Straten PT. Simões AMC, et al. Among authors: holmstrom mo. Front Immunol. 2022 Aug 5;13:970322. doi: 10.3389/fimmu.2022.970322. eCollection 2022. Front Immunol. 2022. PMID: 35990670 Free PMC article.
Antibodies to calnexin and mutated calreticulin are common in human sera.
Kyllesbech C, Trier N, Mughal F, Hansen P, Holmström M, El Fassi D, Hasselbalch H, Skov V, Kjær L, Andersen M, Ciplys E, Slibinskas R, Frederiksen J, Højrup P, Houen G. Kyllesbech C, et al. Curr Res Transl Med. 2023 Apr-Jun;71(2):103380. doi: 10.1016/j.retram.2023.103380. Epub 2023 Jan 28. Curr Res Transl Med. 2023. PMID: 36738659 Free article.
An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial.
Grauslund JH, Holmström MO, Martinenaite E, Lisle TL, Glöckner HJ, El Fassi D, Klausen U, Mortensen REJ, Jørgensen N, Kjær L, Skov V, Svane IM, Hasselbalch HC, Andersen MH. Grauslund JH, et al. Among authors: holmstrom mo. Front Immunol. 2023 Feb 23;14:1117466. doi: 10.3389/fimmu.2023.1117466. eCollection 2023. Front Immunol. 2023. PMID: 36911725 Free PMC article.
Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis.
Kjær L, Skov V, Larsen MK, Boklund TI, Andersen M, Kefala M, Knudsen TA, Schjellerup Eickhardt-Dalbøge C, Stiehl T, Gudmand-Høyer J, Snyder J, Holmström M, Andersen MH, Ottesen JT, Ellervik C, Hasselbalch HC. Kjær L, et al. Front Oncol. 2023 May 8;13:1176173. doi: 10.3389/fonc.2023.1176173. eCollection 2023. Front Oncol. 2023. PMID: 37223675 Free PMC article.
Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow.
Holmström MO, Andersen M, Traynor S, Ahmad SM, Lisle TL, Handlos Grauslund J, Skov V, Kjær L, Ottesen JT, Gjerstorff MF, Hasselbalch HC, Andersen MH. Holmström MO, et al. Front Immunol. 2023 Aug 17;14:1240678. doi: 10.3389/fimmu.2023.1240678. eCollection 2023. Front Immunol. 2023. PMID: 37662956 Free PMC article.
Production and Characterization of Peptide Antibodies to the C-Terminal of Frameshifted Calreticulin Associated with Myeloproliferative Diseases.
Mughal FP, Bergmann AC, Huynh HUB, Jørgensen SH, Mansha I, Kesmez M, Schürch PM, Theocharides APA, Hansen PR, Friis T, Holmström MO, Ciplys E, Slibinskas R, Højrup P, Houen G, Trier NH. Mughal FP, et al. Among authors: holmstrom mo. Int J Mol Sci. 2022 Jun 18;23(12):6803. doi: 10.3390/ijms23126803. Int J Mol Sci. 2022. PMID: 35743246 Free PMC article.
Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies.
Klausen U, Holmberg S, Holmström MO, Jørgensen NGD, Grauslund JH, Svane IM, Andersen MH. Klausen U, et al. Among authors: holmstrom mo. Front Immunol. 2018 Oct 1;9:2264. doi: 10.3389/fimmu.2018.02264. eCollection 2018. Front Immunol. 2018. PMID: 30327655 Free PMC article. Review.
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Kjeldsen JW, Lorentzen CL, Martinenaite E, Ellebaek E, Donia M, Holmstroem RB, Klausen TW, Madsen CO, Ahmed SM, Weis-Banke SE, Holmström MO, Hendel HW, Ehrnrooth E, Zocca MB, Pedersen AW, Andersen MH, Svane IM. Kjeldsen JW, et al. Among authors: holmstrom mo. Nat Med. 2021 Dec;27(12):2212-2223. doi: 10.1038/s41591-021-01544-x. Epub 2021 Dec 9. Nat Med. 2021. PMID: 34887574 Free PMC article. Clinical Trial.
Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV.
Klausen U, Grauslund JH, Jørgensen NGD, Ahmad SM, Jonassen M, Weis-Banke SE, Martinenaite E, Pedersen LB, Lisle TL, Gang AO, Enggaard L, Hansen M, Holmström MO, Met Ö, Svane IM, Niemann CU, Pedersen LM, Andersen MH. Klausen U, et al. Among authors: holmstrom mo. Front Oncol. 2022 Nov 22;12:1023015. doi: 10.3389/fonc.2022.1023015. eCollection 2022. Front Oncol. 2022. PMID: 36483037 Free PMC article.
Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database.
Holmström MO, Gimsing P, Abildgaard N, Andersen NF, Helleberg C, Clausen NA, Klausen TW, Frederiksen M, Kristensen DL, Larsen H, Pedersen PT, Andersen KT, Pedersen RS, Jensen BA, Gregersen H, Vangsted AJ. Holmström MO, et al. Am J Hematol. 2015 Apr;90(4):E73-4. doi: 10.1002/ajh.23932. Epub 2015 Feb 2. Am J Hematol. 2015. PMID: 25561348 Free article. No abstract available.
The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines.
Weis-Banke SE, Hübbe ML, Holmström MO, Jørgensen MA, Bendtsen SK, Martinenaite E, Carretta M, Svane IM, Ødum N, Pedersen AW, Met Ö, Madsen DH, Andersen MH. Weis-Banke SE, et al. Among authors: holmstrom mo. Oncoimmunology. 2020 Jun 1;9(1):1771142. doi: 10.1080/2162402X.2020.1771142. Oncoimmunology. 2020. PMID: 32923127 Free PMC article.
Author Correction: A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Kjeldsen JW, Lorentzen CL, Martinenaite E, Ellebaek E, Donia M, Holmstroem RB, Klausen TW, Madsen CO, Ahmed SM, Weis-Banke SE, Holmström MO, Hendel HW, Ehrnrooth E, Zocca MB, Pedersen AW, Andersen MH, Svane IM. Kjeldsen JW, et al. Among authors: holmstrom mo. Nat Med. 2022 Apr;28(4):871. doi: 10.1038/s41591-022-01771-w. Nat Med. 2022. PMID: 35260843 Free PMC article. No abstract available.
Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy.
Mortensen REJ, Holmström MO, Lisle TL, Hasselby JP, Willemoe GL, Met Ö, Marie Svane I, Johansen J, Nielsen DL, Chen IM, Andersen MH. Mortensen REJ, et al. Among authors: holmstrom mo. J Immunother Cancer. 2023 Mar;11(3):e006432. doi: 10.1136/jitc-2022-006432. J Immunother Cancer. 2023. PMID: 36948507 Free PMC article. Clinical Trial.
The Danish National Multiple Myeloma Registry.
Gimsing P, Holmström MO, Klausen TW, Andersen NF, Gregersen H, Pedersen RS, Plesner T, Pedersen PT, Frederiksen M, Frølund U, Helleberg C, Vangsted A, de Nully Brown P, Abildgaard N. Gimsing P, et al. Among authors: holmstrom mo. Clin Epidemiol. 2016 Oct 25;8:583-587. doi: 10.2147/CLEP.S99463. eCollection 2016. Clin Epidemiol. 2016. PMID: 27822103 Free PMC article. Review.
Immune reconstitution in patients with myelofibrosis conditioned with a non-myeloablative regimen prior to allogeneic stem cell transplantation.
Holmström MO, Minculescu L, Nørgaard K, Hartling HJ, Kornblit BT, Nygaard M, Schjødt I, Andersen MH, Andersen NS, Sengeløv H, Hauge AW, Petersen SL, Andersen MK, Friis LS. Holmström MO, et al. Bone Marrow Transplant. 2026 Apr 8. doi: 10.1038/s41409-026-02850-z. Online ahead of print. Bone Marrow Transplant. 2026. PMID: 41951841 No abstract available.
Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells.
Weis-Banke SE, Lisle TL, Perez-Penco M, Schina A, Hübbe ML, Siersbæk M, Holmström MO, Jørgensen MA, Marie Svane I, Met Ö, Ødum N, Madsen DH, Donia M, Grøntved L, Andersen MH. Weis-Banke SE, et al. Among authors: holmstrom mo. J Immunother Cancer. 2022 Oct;10(10):e005326. doi: 10.1136/jitc-2022-005326. J Immunother Cancer. 2022. PMID: 36316062 Free PMC article.
TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer.
Perez-Penco M, Weis-Banke SE, Schina A, Siersbæk M, Hübbe ML, Jørgensen MA, Lecoq I, Lara de la Torre L, Bendtsen SK, Martinenaite E, Holmström MO, Madsen DH, Donia M, Ødum N, Grøntved L, Andersen MH. Perez-Penco M, et al. Among authors: holmstrom mo. J Immunother Cancer. 2022 Dec;10(12):e005491. doi: 10.1136/jitc-2022-005491. J Immunother Cancer. 2022. PMID: 36600556 Free PMC article.
Individualized Treosulfan-Based Conditioning Improves Outcomes of Allogeneic Hematopoietic Transplantation for Myelodysplastic Syndrome: A 25-Year Retrospective, Population-Based Analysis.
Skovgaard Schovsbo J, Donohue Wedge E, Sengeløv H, Thomas Kornblit B, Schjødt I, Nygaard M, Petersen SL, Andersen NS, Kok Mortensen B, Weber D, Holmström MO, Grønbæk K, Friis LS. Skovgaard Schovsbo J, et al. Among authors: holmstrom mo. Transplant Cell Ther. 2026 Mar;32(3):233.e1-233.e4. doi: 10.1016/j.jtct.2025.11.030. Epub 2025 Nov 28. Transplant Cell Ther. 2026. PMID: 41319918 Free article. No abstract available.
Moving for optimal immunity: the effect of acute high-intensity interval training on phenotype, virus specificity and chemokine receptor expression in human CD8+ T cells.
Leuchte K, Luu TV, Fresnillo Saló S, Madsen K, Heide-Ottosen L, Skadborg SK, Kemming JS, Holmström MO, Chen H, Olsen LR, Vinther A, Andersen MH, Hadrup SR, Thor Straten P, Holmen Olofsson G. Leuchte K, et al. Among authors: holmstrom mo. Front Immunol. 2026 Jan 19;16:1739657. doi: 10.3389/fimmu.2025.1739657. eCollection 2025. Front Immunol. 2026. PMID: 41675500 Free PMC article.
Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer.
Grützmeier SE, Kovacevic B, Vilmann P, Rift CV, Melchior LC, Holmström MO, Brink L, Hassan H, Karstensen JG, Grossjohann H, Chiranth D, Toxværd A, Hansen CP, Høgdall E, Hasselby JP, Klausen P. Grützmeier SE, et al. Among authors: holmstrom mo. Cancers (Basel). 2023 Jul 19;15(14):3677. doi: 10.3390/cancers15143677. Cancers (Basel). 2023. PMID: 37509338 Free PMC article.
The antitumor activity of TGFβ-specific T cells is dependent on IL-6 signaling.
Perez-Penco M, Byrdal M, Lara de la Torre L, Ballester M, Khan S, Siersbæk M, Lecoq I, Madsen CO, Kjeldsen JW, Svane IM, Hansen M, Donia M, Johansen JS, Olsen LR, Grøntved L, Chen IM, Arnes L, Holmström MO, Andersen MH. Perez-Penco M, et al. Among authors: holmstrom mo. Cell Mol Immunol. 2025 Jan;22(1):111-126. doi: 10.1038/s41423-024-01238-7. Epub 2024 Dec 9. Cell Mol Immunol. 2025. PMID: 39653766 Free PMC article.
First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer.
Mørk SK, Kongsted P, Westergaard MCW, Albieri B, Granhøj JS, Donia M, Martinenaite E, Holmström MO, Madsen K, Kverneland AH, Kjeldsen JW, Holmstroem RB, Lorentzen CL, Nørgaard N, Andreasen LV, Wood GK, Christensen D, Klausen MS, Hadrup SR, Thor Straten P, Andersen MH, Svane IM. Mørk SK, et al. Among authors: holmstrom mo. Front Immunol. 2023 Mar 14;14:1122977. doi: 10.3389/fimmu.2023.1122977. eCollection 2023. Front Immunol. 2023. PMID: 36999039 Free PMC article.
Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis. A Population-Based Study from Eastern Denmark.
Holmström MO, Minculescu L, Nørgaard K, Kornblit BT, Schjødt I, Nygaard M, Andersen NS, Sengeløv H, Bruunsgaard H, Petersen SL, Andersen MK, Friis LS. Holmström MO, et al. Transplant Cell Ther. 2025 Jun;31(6):365.e1-365.e13. doi: 10.1016/j.jtct.2025.03.006. Epub 2025 Mar 17. Transplant Cell Ther. 2025. PMID: 40107383 Free article.